Reuters logo
BRIEF-Cadila Healthcare's ‍Zydus gets final FDA nod for skin disorder, hypertension drugs
September 20, 2017 / 7:20 AM / a month ago

BRIEF-Cadila Healthcare's ‍Zydus gets final FDA nod for skin disorder, hypertension drugs

Sept 20 (Reuters) - Cadila Healthcare Ltd:

* Says ‍zydus receives final approval from USFDA for desoximetasone ointment and labetalol hydrochloride tablets​

* Says drug to be manufactured at group’s topical facility at Ahmedabad

* Says labetalol to be manufactured at formulations facility at pharma SEZ, Ahmedabad Source text: bit.ly/2hgKC0Y Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below